Clinical Trial Update: Optimization of Keverprazan-amoxicillin Dual Therapy for Eradicating Helicobacter Pylori Infection [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating a dual therapy of Keverprazan and amoxicillin to eradicate Helicobacter pylori infection is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• AMOXICILLIN (AMOXICILLIN)
• Keverprazan

Snippet

Sponsor: Eighth Affiliated Hospital, Sun Yat-sen University | Conditions: Helicobacter Pylori Eradication Rate | Phase 3 | Status: RECRUITING